Navigation Links
Concord Medical Reports Fourth Quarter and Full Year 2012 Financial Results
Date:3/20/2013

ble law.

Statement Regarding Unaudited Financial InformationThe Company's independent auditors are in the process of completing an audit of the Company's U.S. GAAP financial statements for 2011. These unaudited 2011 numbers disclosed in this announcement are, therefore, subject to change.

About Non-GAAP Financial Measures To supplement the consolidated financial statements presented in accordance with United States Generally Accepted Accounting Principles (GAAP), Concord Medical uses certain non-GAAP measures.  The Company presents certain of its financial information that is adjusted from results based on GAAP to exclude the impact of share-based compensation expense. The Company believes excluding share-based compensation expense from its non-GAAP financial measures is useful for its management and investors to assess and analyze the Company's core operating results as such expense is not directly attributable to the underlying performance of the Company's business operations and do not impact its cash earnings. Concord Medical also believes these non-GAAP measures excluding share-based compensation expense are important in helping investors to understand the Company's current financial performance and future prospects and to compare business trends among different reporting periods on a consistent basis. In addition, Concord Medical also presents the non-GAAP measure of Adjusted EBITDA, which is defined in this announcement as net (loss) income plus interest, taxes, depreciation and amortization, share-based compensation expenses and other adjustments. Other adjustments include change in fair value of convertible notes, foreign exchange loss and other income. Furthermore, Adjusted EBITDA eliminates the impact of items that the Company does not consider indicative of the performance of its network of centers. The Company believes investors will similarly use Adjusted EBITDA as one of the key metrics to evaluate its financial performance and to c
'/>"/>

SOURCE Concord Medical Services Holdings Limited
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine technology :

1. Concord Medical to Report Fourth Quarter and Full Year 2012 Financial Results on March 20, 2013
2. DDS Lab Announces Strategic Alliance with United Concordia
3. Concord Medical Acquires Ownership Interest in MD Anderson Cancer Center Proton Therapy Center
4. Concord Medical to Hold Annual General Meeting on December 22, 2012
5. Concord Medical Reports Third Quarter 2012 Financial Results
6. Concord Medical Announces Change to Third Quarter Financial Results Date to November 20, 2012
7. Concord Medical to Report Third Quarter 2012 Financial Results on November 21, 2012
8. Concord Medical Responds to Unusual Market Activity in its Stock
9. Concord Medical Reports Second Quarter 2012 Financial Results
10. Concord Medical to Report Second Quarter 2012 Financial Results on August 20, 2012
11. Concordia Study Indicates Obesity is Becoming the Nations Top Health Issue
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... , Sept. 4, 2015  Janssen Research & Development, ... Drug Administration (FDA) has accepted for Priority Review ... a treatment for patients with multiple myeloma who ... and an immunomodulatory agent (IMiD), or who have ... including a PI and an IMiD. This is ...
(Date:9/4/2015)... Sept. 4, 2015  Pharmaceutical companies today rely ... Field-Based Medical Specialists (FBMS) to build and strengthen ... thought leaders in critical therapeutic areas. ... teams, companies are expanding the critical MSL function ... with corporate objectives and to achieve regional consistency, ...
(Date:9/4/2015)... Today, the Centers for Disease Control and Prevention (CDC) ... for States , a new program to help states ... Prevention for States program, as part of the ... will make a strong investment in 16 states, giving ... prevent overdose deaths related to prescription opioids. The program ...
Breaking Medicine Technology:U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 2U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 3U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 4U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 5U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 6U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 7New Study Presents Tactics and Insights on How to Effectively Globalize Medical Science Liaison Programs in the Pharmaceutical Industry 2CDC funding helps states combat prescription drug overdose epidemic 2CDC funding helps states combat prescription drug overdose epidemic 3
... Ranbaxy Laboratories Inc. (RLI), a wholly owned subsidiary of ... U.S. Food and Drug Administration (FDA) has approved Absorica™, ... isotretinoin, for the treatment of severe recalcitrant nodular acne. ... Pharmaceuticals Inc., RLI is expected to launch Absorica™ in ...
... May 29, 2012 Oramed Pharmaceuticals Inc. ... drug delivery systems, announced today that it has received ... Patent Office. The patent, entitled "Methods and Compositions for ... using the company,s technology. Oramed,s portfolio now consists of ...
Cached Medicine Technology:Ranbaxy Announces U.S. FDA Approval of CIP-Isotretinoin NDA 2Oramed Pharmaceuticals Granted Core Technology Patent in New Zealand 2Oramed Pharmaceuticals Granted Core Technology Patent in New Zealand 3
(Date:9/4/2015)... , ... September 04, 2015 , ... ... the surrounding communities, is launching a charity effort to provide for the family ... to as an enlarged heart, restrictive cardiomyopathy often leads to diastolic dysfunction – ...
(Date:9/4/2015)... ... September 04, 2015 , ... A Union County ... Core Compassion Project is a non-profit organization dedicated to offering Pilates scholarships ... of cancer treatments and recover their mobility, strength, and range of motion following ...
(Date:9/4/2015)... ... September 04, 2015 , ... San ... available at CitiDent. CEREC is a newer method for creating restorations through innovative ... patients by eliminating the need for multiple appointments, CEREC produces restorations with total ...
(Date:9/4/2015)... ... September 04, 2015 , ... Many consumers are looking for a quick and convenient way ... , The patent-pending K Med Cups provide a quick and simple way to brew a ... cold, flu or cough. As a result, they enhance comfort and health. The invention features ...
(Date:9/4/2015)... Portland, ME (PRWEB) , ... September 04, 2015 ... ... Symposium focus on: the microbiome taking place in Hollywood, Florida October 9-10, 2015 ... ihsymposium.com/focus-event. , Speakers at the 2015 symposium are doctors and researchers at the ...
Breaking Medicine News(10 mins):Health News:Georgia Insurance Advisors Inaugurates Charity Drive to Assist the Family of Young Local Girl Diagnosed with an Enlarged Heart 2Health News:Georgia Insurance Advisors Inaugurates Charity Drive to Assist the Family of Young Local Girl Diagnosed with an Enlarged Heart 3Health News:Girl’s Night Out to Benefit Core Compassion Project, Located at the Beautiful, Morning Glory Farm 2Health News:San Francisco Dentist, Dr. Ben Amini, is Now Offering CEREC Technology at CitiDent 2Health News:Redesigned Packaging for Powdered Medicinal Mix Invented by InventHelp® Client (CBA-2637) 2Health News:Integrative Healthcare Symposium Focus On: The Microbiome Conference Program Announced 2
... As Both a Membership Card and Debit Card for Health-related ... and inconvenience often associated with a Flexible Spending Account (FSA) ... This card - which is unique to Western Pennsylvania - ... as a debit card for out-of-pocket health care expenses.The ...
... laughing gas may be enhanced by suggestion or ... College London). The study,s findings that people are ... patients may benefit from being coached to relax while ... used by dentists to sedate their patients before treatment, ...
... Nationally With More than 1,800 in Florida Alone ST. ... medical identification franchise, announced today the launch of its ... device to consumers containing their comprehensive medical history. ... their private medical history on an easy-to-carry or wearable ...
... Financial Group is pleased to announce that James D. Hohman, ... as one of the "150 Best Financial Advisors for Doctors ... is one of only six advisors from Pennsylvania included in ... , , Candidates were selected to the list ...
... even today,s) health problems may be found among the ... ShowLAS VEGAS, Jan. 9 /PRNewswire-USNewswire/ -- ... way we shop, listen to music, and even stay ... an illness or disability remains a frightening, stressful, and ...
... says the drugs should only be used short-term, ... News) -- Alzheimer,s patients who are prescribed antipsychotic ... similar patients not given these medications do, British ... antipsychotics has been found to benefit Alzheimer,s patients, ...
Cached Medicine News:Health News:UPMC Health Plan Introduces `MyFlex Advantage' Card 2Health News:UPMC Health Plan Introduces `MyFlex Advantage' Card 3Health News:People are more suggestible under laughing gas 2Health News:People are more suggestible under laughing gas 3Health News:World's First Medical Identification Franchise Launches at Miami's Franchise Expo South 2Health News:World's First Medical Identification Franchise Launches at Miami's Franchise Expo South 3Health News:Meridian Makes CES Good For Your Health 2Health News:Antipsychotics Up Death Risk in Alzheimer's Patients 2Health News:Antipsychotics Up Death Risk in Alzheimer's Patients 3
... 48-capillary 3730 DNA Analyzer, upgradeable to 96 ... DNA analysis. , Higher optical sensitivity ... higher-quality data at a lower cost. , ... , Optimized polymers increase your productivity without ...
... this unique offer, you can ... application. Pipetman P2 and P10 ... reagents, and P100 is perfect ... Filter Tips, which are especially ...
... is an immunochromatography based one step ... qualitative determination of Methamphetamine in human ... 1000 ng/mL. This assay has not ... care,location and is for use by ...
... The RapidAMP test is an ... test. It is,designed for qualitative determination ... above,a cut-off level of 1000 ng/mL. ... in the point of care,location and ...
Medicine Products: